We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Image: Access p-Tau217 is a blood test designed to support amyloid pathology evaluation in patients with cognitive decline (Photo courtesy of Beckman Coulter)

Blood Test Brings Alzheimer’s Biomarker Assessment to Routine Labs

Beckman Coulter Diagnostics has received IVDR CE Mark for the Access p-Tau217, a blood test supporting amyloid pathology evaluation. More...
09 Jul 2026
Image: A new AI assistant supports treatment decisions in complex blood cancers (Image Credit: Shutterstock)

AI Decision Support System Guides Treatment Selection for Complex Blood Cancers

An AI approach supports treatment selection in hematologic malignancies, matching tumor board decisions in 82% of cases. More...
08 Jul 2026
Image: WHO has added the first molecular diagnostic test for Bundibugyo virus to its Emergency Use Listing, enabling rapid detection in blood samples (Image Credit: Adobe Stock)

WHO Adds First Bundibugyo Ebola Molecular Test to Emergency Use Listing

The World Health Organization has added the first molecular diagnostic test for Bundibugyo virus to its Emergency Use Listing. More...
08 Jul 2026
Image Credit: 123RF

Study Supports Earlier Genetic Testing for Hereditary Breast and Ovarian Cancer

New data show nearly 20% of healthy relatives harbor pathogenic variants, supporting earlier, systematic cascade testing. More...
08 Jul 2026
Image: New oral cancer brush test diagram (Teh, MT., Patil, R., Tekade, S.A. et al. Biomark Research, 2026. https://doi.org/10.1186/s40364-026-00963-7)

Rapid Brush Biopsy Test Detects Oral Cancer in One Hour

An oral brush molecular test detects oral cancer in one hour, reducing unnecessary biopsies. More...
08 Jul 2026
Image: Traditional vs. Biomarker-Based Methods for Colorectal Cancer (CRC) Detection. Traditional CRC detection methods such as colonoscopy, stool-based test (FIT & FOBT), and CT colonography are depicted above. Below, emerging biomarker-based approaches including genomics, gut microbiome, and metabolomic and proteomic profiles are illustrated. (Reem A. Qannita et al., Clinica Chimica Acta, 2026. DOI: 10.1016/j.cca.2026.121013

Noninvasive Biomarkers Advance Colorectal Cancer Risk Assessment

New findings highlight minimally invasive ctDNA and miRNA biomarkers that improve early colorectal cancer detection. More...
08 Jul 2026
Image: A new computational framework makes genomic surveillance faster and more cost-effective for emerging COVID-19 strains (Image Credit: 123RF)

Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants

A new algorithmic framework for global genomic surveillance speeds variant detection and cuts costs. More...
08 Jul 2026
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Automated Clinical Chemistry Analyzer
Envoy 500+
Copyright © 2000-2026 Globetech Media. All rights reserved.